Nanotechnology: A Promising Approach for Drug Delivery

Dear Colleagues,

Nanotechnology encompasses a platform in which chemistry, biology, physics, engineering, and medicine are combined. In this sense, nanomedicine is one of the leading applications of nanotechnology and the development of delivery systems that allow drugs to be directed to target sites can result in efficient treatment by reducing off-target effects and toxicity. Moreover, nanomaterials are versatile tools that can be tailored to fulfill an intended purpose due to their unique functional characteristics and features. Nanoparticles (NPs) are the platform of choice for drug delivery and include organic, inorganic, metallic and polymer-based NPs including liposomes, micelles, and dendrimers and the efficacy of these NPs is determined by shape, size, and inherent biophysical/chemical factors. In line with this trend, Pharmaceutics will devote a Special Issue entitled “Nanotechnology: A Promising Approach for Drug Delivery” that will include original research articles and comprehensive reviews in this field. The topics of interest include but are not limited to the following:

• Functionalized nanomaterials for cancer therapy, respiratory diseases, ocular applications, cardiovascular diseases, dermatology, neurological disorders, gastroenterology;
• Functionalized nanomaterials for infection treatment;
• Novel approaches for drug delivery and controlled drug release.

Prof. Dr. Silvia Edith Lucangioli
Prof. Dr. Valeria Tripodi
Dr. Cecilia B. Dobrecky
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.